Israel Ben-yoram, Director at PLURISTEM THERAPEUTICS INC (PSTI), bought 30,000 shares at $2.14 ($63K) on 2015-09-21, disclosed to the SEC on 2015-09-24.
Open-market purchase of $63k PSTI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.07 | 12,300 | $25K | 40.6% |
| 2 | $2.08 | 3,200 | $7K | 10.6% |
| 3 | $2.09 | 100 | $209 | 0.3% |
| 4 | $2.10 | 7,200 | $15K | 24.1% |
| 5 | $2.11 | 3,900 | $8K | 13.1% |
| 6 | $2.14 | 3,300 |
| $7K |
| 11.3% |
| Total | $2.09 avg | 30,000 | $63K | 100% |
| Filing → |
| PSTI | BUY | 2014-09-18 | $14K | — | Filing → |
| PSTI | SELL | 2014-01-21 | $161K | — | Filing → |
| PSTI | SELL | 2014-01-14 | $114K | — | Filing → |